Search Results 261-270 of 17114 for monoclonal antibody

1. Skin Cancer Clinical Trials - Mayo Clinic Research

   Monoclonal antibodies, such as pembrolizumab, may interfere with the ability of tumor cells to grow and spread. Giving imiquimod and pembrolizumab may work ...

2. Alzheimer's drug lecanemab granted full approval by FDA, Mayo Clinic expert weighs in

   A monoclonal antibody, lecanemab, shows promise in removing amyloid plaques from the brain, according to phase 3 trial results. Amyloid plaques are one of ...

3. Non-Small Cell Lung Cancer Clinical Trials - Mayo Clinic Research

   Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor ...

4. Otolaryngology (ENT)/Head and Neck Surgery - Clinical trials

   Monoclonal antibodies, such as cetuximab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find ...

5. Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy - Mayo Clinic

   Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer ...

6. Margetuximab-cmkb (intravenous route) - Side effects & uses - Mayo Clinic

   Margetuximab-cmkb is a monoclonal antibody that changes the immune system to help control the growth of cancer cells. This medicine is to be given only by ...

7. Clinical trials - Oncology (Medical)

   Monoclonal antibodies, such as inotuzumab ozogamicin, may block cancer growth in different ways by targeting certain cells. Drugs used in chemotherapy work ...

8. Anaplastic Thyroid Cancer Clinical Trials - Mayo Clinic Research

   Monoclonal antibodies, such as pembrolizumab, may interfere with the ability of tumor cells to grow and spread. Drugs used in chemotherapy, such as ...

9. OCEAN (depemOkimab effiCacy Eosinophilic grAnulomatosis with polyaNgiitis) - Mayo Clinic

   Depemokimab is a humanised, affinity matured monoclonal antibody that blocks human interleukin-5 (IL-5) binding to its receptor. Depemokimab is being ...

10. Pembrolizumab With or Without Anetumab Ravtansine in Treating Patients With Mesothelin-Positive Pleural Mesothelioma - Mayo Clinic

    Monoclonal antibodies, such as anetumab ... Patients who have received any monoclonal antibody therapy within 4 weeks prior to entering the study.